NasdaqGM:ALVOBiotechs
Alvotech (ALVO) Could Be 72% Undervalued Following FDA Inspection Closure
Alvotech (NasdaqGM:ALVO) is back in focus after the U.S. Food and Drug Administration closed its May 2026 inspection of the Reykjavik manufacturing facility with a Voluntary Action Indicated classification.
See our latest analysis for Alvotech.
The FDA update and fresh BLA activity have arrived during a sharp swing in sentiment toward Alvotech, with a 7 day share price return of 23.87% contrasting with a year to date share price decline of 23.20% and a 1 year total shareholder return that is...